STAB logo

Statera Biopharma (STAB) Operating Profit

Annual Operating Profit

-$30.74 M
-$19.72 M-178.78%

December 31, 2021


Summary


Performance

STAB Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSTABprofitabilitymetrics:

Quarterly Operating Profit

-$1.47 M
+$1.27 M+46.46%

September 30, 2022


Summary


Performance

STAB Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSTABprofitabilitymetrics:

TTM Operating Profit

-$19.98 M
+$7.34 M+26.87%

September 30, 2022


Summary


Performance

STAB TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSTABprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

STAB Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-178.8%+83.3%+17.8%
3 y3 years-992.4%-1211.3%-10000.0%
5 y5 years-992.4%-1211.3%-10000.0%

STAB Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+84.3%at high+34.7%
5 y5-year-992.4%at low-1211.3%+84.3%<-9999.0%+34.7%
alltimeall time-992.4%at low-1211.3%+84.3%<-9999.0%+34.7%

Statera Biopharma Operating Profit History

DateAnnualQuarterlyTTM
Sep 2022
-
-$1.47 M(-46.5%)
-$19.98 M(-26.9%)
Jun 2022
-
-$2.74 M(-57.2%)
-$27.32 M(-10.7%)
Mar 2022
-
-$6.40 M(-31.8%)
-$30.61 M(+4.4%)
Dec 2021
-$30.74 M
-$9.38 M(+6.4%)
-$29.32 M(+20.7%)
Sep 2021
-
-$8.81 M(+46.1%)
-$24.29 M(+13.4%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$6.03 M(+18.2%)
-$21.43 M(+39.2%)
Mar 2021
-
-$5.10 M(+17.2%)
-$15.40 M(+47.9%)
Dec 2020
-$11.03 M(+291.9%)
-$4.35 M(-26.8%)
-$10.41 M(+71.9%)
Sep 2020
-
-$5.95 M(+5214.5%)
-$6.06 M(+5314.5%)
Mar 2020
-
-$111.90 K
-$111.90 K
Dec 2019
-$2.81 M
-
-

FAQ

  • What is Statera Biopharma annual operating income?
  • What is the all time high annual operating profit for Statera Biopharma?
  • What is Statera Biopharma annual operating profit year-on-year change?
  • What is Statera Biopharma quarterly operating income?
  • What is the all time high quarterly operating profit for Statera Biopharma?
  • What is Statera Biopharma quarterly operating profit year-on-year change?
  • What is Statera Biopharma TTM operating income?
  • What is the all time high TTM operating profit for Statera Biopharma?
  • What is Statera Biopharma TTM operating profit year-on-year change?

What is Statera Biopharma annual operating income?

The current annual operating profit of STAB is -$30.74 M

What is the all time high annual operating profit for Statera Biopharma?

Statera Biopharma all-time high annual operating income is -$2.81 M

What is Statera Biopharma annual operating profit year-on-year change?

Over the past year, STAB annual operating income has changed by -$19.72 M (-178.78%)

What is Statera Biopharma quarterly operating income?

The current quarterly operating profit of STAB is -$1.47 M

What is the all time high quarterly operating profit for Statera Biopharma?

Statera Biopharma all-time high quarterly operating income is -$111.90 K

What is Statera Biopharma quarterly operating profit year-on-year change?

Over the past year, STAB quarterly operating income has changed by +$7.34 M (+83.34%)

What is Statera Biopharma TTM operating income?

The current TTM operating profit of STAB is -$19.98 M

What is the all time high TTM operating profit for Statera Biopharma?

Statera Biopharma all-time high TTM operating income is -$111.90 K

What is Statera Biopharma TTM operating profit year-on-year change?

Over the past year, STAB TTM operating income has changed by +$4.32 M (+17.76%)